Medeleanu Maria, Upton Julia E M, Reyna Vargas Myrtha E, Dai Ruixue, Mandhane Piushkumar J, Simons Elinor, Turvey Stuart E, Subbarao Padmaja, Moraes Theo J
Translational Medicine Program, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
J Allergy Clin Immunol Glob. 2022 Jan 17;1(2):73-79. doi: 10.1016/j.jacig.2021.12.005. eCollection 2022 May.
Respiratory infections in infancy are associated with the development of allergic asthma and atopy. Delineating whether symptomatic infections are a marker of atopic predisposition or contribute to atopic development is important for preventive strategies. We hypothesized that early, severe lower respiratory tract infections (LRTIs) may be a risk factor for the development of atopic disease.
Our aim was to determine whether clinically defined, moderate-to-severe LRTIs in infancy are associated with the development of atopic dermatitis and allergic sensitization at preschool age.
LRTI timing and severity in the first 18 months of life was defined by using the Canadian Healthy Infant Longitudinal Development study questionnaires. Polysensitization and atopic dermatitis were determined by standardized skin prick testing and structured clinical assessments. Longitudinal associations between LRTI severity and clinical outcomes at ages 3 years and 5 years were determined by adjusted repeated measures generalized estimation equations.
Moderate-to-severe LRTIs were associated with increased odds of polysensitization (odds ratio = 1.91 [95% CI = 1.16-3.15]; = .014) and atopic dermatitis (odds ratio = 2.19 [95% CI 1.41-3.39]; < .001) as compared with the odds in children with no history of LRTI in the first 18 months of life. The association between moderate-to-severe LRTI and polysensitization or atopic dermatitis remained robust after adjusting for sex; study site; breast-feeding duration; and mother, father, or both-parent atopy or asthma.
These results highlight severe infant LRTI as an important risk factor for allergic and atopic disease (ie, polysensitization and atopic dermatitis), and they suggest that this risk is independent of maternal environment, both-parent history of asthma, and both-parent genetic predisposition.
婴儿期的呼吸道感染与过敏性哮喘和特应性疾病的发生有关。明确有症状的感染是特应性易感性的标志还是促成特应性疾病的发展,对于预防策略而言至关重要。我们推测早期、严重的下呼吸道感染(LRTIs)可能是特应性疾病发生的一个危险因素。
我们的目的是确定婴儿期临床定义的中度至重度LRTIs是否与学龄前儿童特应性皮炎和过敏致敏的发生有关。
通过使用加拿大健康婴儿纵向发育研究问卷来确定生命最初18个月内LRTI的时间和严重程度。通过标准化皮肤点刺试验和结构化临床评估来确定多致敏和特应性皮炎情况。通过调整后的重复测量广义估计方程来确定18个月时LRTI严重程度与3岁和5岁时临床结局之间的纵向关联。
与生命最初18个月内无LRTI病史的儿童相比,中度至重度LRTIs与多致敏几率增加(优势比 = 1.91 [95%可信区间 = 1.16 - 3.15];P = 0.014)和特应性皮炎几率增加(优势比 = 2.19 [95%可信区间1.41 - 3.39];P < 0.001)相关。在对性别、研究地点、母乳喂养持续时间以及母亲、父亲或双亲的特应性或哮喘进行校正后,中度至重度LRTI与多致敏或特应性皮炎之间的关联仍然显著。
这些结果突出了严重婴儿LRTI作为过敏性和特应性疾病(即多致敏和特应性皮炎)的一个重要危险因素,并且表明这种风险独立于母亲环境、双亲哮喘病史和双亲遗传易感性。